MedTrace Logo

Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease

NCT05719233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-01-12

No results posted yet for this study

Summary

Research on the impact of lung diseases on neuropsychological functioning has revealed impaired cognitive processing in patients with a variety of pulmonary disorders. While the mechanisms responsible for the association of pulmonary diseases and neurocognitive functioning remain unclear, some researchers have attributed it to reduced oxygenation of the brain. Early detection and accurate management of comorbidity have benefits in reducing ILD morbidity and mortality.

Conditions

  • Lung Diseases, Interstitial

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Waleed Gamal Elddin Khaleel, Lecturer · Assiut university, Egypt

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-09-01
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05719233 on ClinicalTrials.gov